Emer Leahy - 16 Jul 2026 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Jul 2026, 16:03:18 UTC
Prior SEC filing
05 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kostantinos Skordalos, Attorney-in-fact

Key filing fact

Emer Leahy filed Form 4 for INTENSITY THERAPEUTICS, INC. (INTS) on 20 Jul 2026.

Key facts

  • This page summarizes Emer Leahy's Form 4 filing for INTENSITY THERAPEUTICS, INC. (INTS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 20 Jul 2026, 16:03.

Change

  • Previous filing in this sequence was filed on 05 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001875180 Primary reporting owner

Leahy Emer

Relationship
Director
Address
C/O INTENSITY THERAPEUTICS, INC., 1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Signature
/s/ Kostantinos Skordalos, Attorney-in-fact
Signature date
20 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INTS transaction Derivative

Stock Option (right to buy Common Stock)

Award

Transaction value
Shares
+5,500
Change %
Price
$0.000000*
Shares after
5,500
Date
16 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,500
Exercise price
$4.90
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .